Johannes Gutenberg-Universität Mainz
- 6131/39-0
Mueller-Dahlhaus, Florian; Bergmann, Til Ole
Network perturbation-based biomarkers of depression and treatment responseCELL REPORTS MEDICINE. Bd. 4. H. 6. 2023
Nardi, Leonardo; Chhabra, Stuti; Leukel, Petra et al.
Neuroanatomical changes of ionotropic glutamatergic and GABAergic receptor densities in male mice modeling idiopathic and syndromic autism spectrum disorderFRONTIERS IN PSYCHIATRY. Bd. 14. 2023
Bersano, A.; Engele, J.; Schafer, M. K. E.
Neuroinflammation and Brain DiseaseBMC NEUROLOGY. Bd. 23. H. 1. 2023
Allendoerfer, Jens; Groeschel, Klaus; Harrer-Haag, Judith U. et al.
Neurological ultrasound diagnostics - an updateKLINISCHE NEUROPHYSIOLOGIE. Bd. 54. H. 04. 2023 S. 231-244
Reuss, Stefan; Balmaceda, Daniel; Elgurt, Mirra et al.
Neuronal Cytoglobin in the Auditory Brainstem of Rat and Mouse: Distribution, Cochlear Projection, and Nitric Oxide ProductionBRAIN SCIENCES. Bd. 13. H. 1. 2023
Schlegelmilch, Anna-Lena; Schillner, Miriam; Zipp, Frauke et al.
Neuronal intracellular calcium storage release upon direct T-cell-neuron interactionMULTIPLE SCLEROSIS JOURNAL. Bd. 29. 2023 S. 497-498
Schaenzer, Anne; Dittmayer, Carsten; Weis, Joachim et al.
Neuropathology II: diseases of the central and peripheral nervous systems Outlook on new techniques in electron microscopyPATHOLOGIE. Bd. 44. H. 2. 2023 S. 113-119
Wu, Linda; Fulgenzi, Claudia A. M.; D'Alessio, Antonio et al.
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023 S. 504-504
Ugurel, Selma; Schmidberger, Heinz
New trends in melanoma From adjuvant therapy in stage II to novel treatment strategies with ImmTACsONKOLOGIE. Bd. 29. H. 8. 2023 S. 656-659
Giampaolo, Sabrina; Chiarolla, Cristina M.; Knoepper, Konrad et al.
NFATc1 induction by an intronic enhancer restricts NKT yδ cell formationISCIENCE. Bd. 26. H. 3. 2023